Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors.
about
Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cellsLung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposureLung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromiumThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsEfficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis.Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth.High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)Multiple roles and therapeutic implications of Akt signaling in cancer.Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistanceAkt1 deletion prevents lung tumorigenesis by mutant K-ras.Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancerExpression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cellsOpposing functions of Akt isoforms in lung tumor initiation and progressionPre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss.Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancerPrognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinomaTumstatin 185-191 increases the sensitivity of non-small cell lung carcinoma cells to cisplatin by blocking proliferation, promoting apoptosis and inhibiting Akt activation.Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell CancerMicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathwayRole of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT PathwayElderly patients with advanced colorectal cancer: which therapy is the safest?Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancerFoxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancerTargeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.Prediction of functional phosphorylation sites by incorporating evolutionary informationThe chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.Repositioning HIV protease inhibitors as cancer therapeuticsOverexpression of CD44 is associated with the occurrence and migration of non-small cell lung cancerAkt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.Prognostic and predictive factors in resected non-small-cell lung cancer.
P2860
Q21090858-C3D98D91-8AAD-402F-AE2B-E5B0B339FCBBQ28392910-17170176-EF19-470A-BEB3-7EE207C53751Q28397511-CEA5107C-5D7B-4B6F-80A5-17558C5C026DQ30365726-2198AB20-7A22-4DAF-A59D-9D62B7D9EFAEQ33385120-E6AB67B4-23FC-45D5-9D6C-482CE39C8F4BQ33425221-F251A9EB-764D-4D4E-88C8-1E3EBE06D052Q33584802-D605538D-359C-40F6-AB34-174978570A24Q33645556-7ACF2FFD-7A92-4A01-A9A0-F2E6B91D280BQ33717222-92B1C8AE-D65F-42C2-8093-C3E4BB5941EDQ33915992-9CA4AA3C-3C21-46A6-A5FC-C4CAB30C88C8Q33990934-215377BD-9E8D-4803-BF8B-85DA24097E14Q34009646-D96FCF50-E3F3-4AA6-A14C-3CA40CEDECCCQ34049042-ED647082-2BF9-4373-AA36-A92617A51C74Q34170007-87707C0F-76AA-49EF-9606-B3C8D984430DQ34254614-2DC2CEF5-AB26-4F88-89DA-B0A83694273EQ34516556-9582F576-CDE5-4237-9530-5AA4D97BDD36Q35034550-6D1B713E-2324-4DA5-AF8D-457B0D0237DEQ35095146-EA491933-95FE-45F4-82C0-C9AB356C0B77Q35145125-875A05E1-C2FE-4819-9139-F8B336234B51Q35149656-ABAE590E-69D8-441C-8B13-9E959256E611Q35256618-12106D2A-AD36-43A7-829D-194C9AD7DE4EQ35741627-6A21F60F-F58D-47FF-89C6-7C947CA7C146Q35784481-3E41CB0D-0B80-4791-886E-4EF7305DEFDCQ35875753-9A506506-0676-41B7-9B4F-50716AB3410CQ35945582-AFB44939-C2A8-43FD-8A51-EBB586DE95A3Q35994228-2B8FCD53-66B3-4517-80FE-78CF46D986D8Q36255950-D268C346-965E-4E3B-AD7E-5196093B14F8Q36299980-BA7352AC-C55D-44ED-82B3-7066C05A99B6Q36464689-014D86D3-D71E-478D-A2DA-32A997BA2539Q36528118-4E239AB4-6671-481B-A737-231C50212082Q36643018-E3DD3529-C48F-41CC-BC07-0CE40D33B5E2Q36688942-21891D08-D7DD-4169-8824-B7642DD7259FQ36742629-483B3384-CEC7-4E3D-8B04-8B0C4488ADA4Q36772120-1A0C0B18-8910-435E-969B-D81B839DC775Q36922913-C2C75204-0405-4512-8B8E-2A52F698222EQ37023660-65D40ADF-0287-4B8A-9CCF-005E04E0532FQ37192579-53C78B1D-2054-43D8-ACFF-0000E76D3FDBQ37297603-29141854-A8C6-4AFD-BD38-4733B5F9C0E3Q37717138-498D9F9E-B3AA-4763-BE00-A5942DF43EA4Q38089884-8A5E1738-54AE-48DE-90A1-CE871AAE08C6
P2860
Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evaluation of two phosphorylat ...... small-cell lung cancer tumors.
@en
type
label
Evaluation of two phosphorylat ...... small-cell lung cancer tumors.
@en
prefLabel
Evaluation of two phosphorylat ...... small-cell lung cancer tumors.
@en
P2093
P356
P1476
Evaluation of two phosphorylat ...... small-cell lung cancer tumors.
@en
P2093
Hiroko Tsurutani
Joanna H Shih
Junji Tsurutani
Junya Fukuoka
Phillip A Dennis
William D Travis
P304
P356
10.1200/JCO.2005.02.4133
P407
P577
2005-12-05T00:00:00Z